Weiner Lindsey M, Fridkin Scott K, Aponte-Torres Zuleika, Avery Lacey, Coffin Nicole, Dudeck Margaret A, Edwards Jonathan R, Jernigan John A, Konnor Rebecca, Soe Minn M, Peterson Kelly, Clifford McDonald L
Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, CDC.
Am J Transplant. 2016 Jul;16(7):2224-30. doi: 10.1111/ajt.13893.
Healthcare-associated antibiotic-resistant (AR) infections increase patient morbidity and mortality and might be impossible to successfully treat with any antibiotic. CDC assessed healthcare-associated infections (HAI), including Clostridium difficile infections (CDI), and the role of six AR bacteria of highest concern nationwide in several types of healthcare facilities.
During 2014, approximately 4000 short-term acute care hospitals, 501 long-term acute care hospitals, and 1135 inpatient rehabilitation facilities in all 50 states reported data on specific infections to the National Healthcare Safety Network. National standardized infection ratios and their percentage reduction from a baseline year for each HAI type, by facility type, were calculated. The proportions of AR pathogens and HAIs caused by any of six resistant bacteria highlighted by CDC in 2013 as urgent or serious threats were determined.
In 2014, the reductions in incidence in short-term acute care hospitals and long-term acute care hospitals were 50% and 9%, respectively, for central line-associated bloodstream infection; 0% (short-term acute care hospitals), 11% (long-term acute care hospitals), and 14% (inpatient rehabilitation facilities) for catheter-associated urinary tract infection; 17% (short-term acute care hospitals) for surgical site infection, and 8% (short-term acute care hospitals) for CDI. Combining HAIs other than CDI across all settings, 47.9% of Staphylococcus aureus isolates were methicillin resistant, 29.5% of enterococci were vancomycin resistant, 17.8% of Enterobacteriaceae were extended-spectrum beta-lactamase phenotype, 3.6% of Enterobacteriaceae were carbapenem resistant, 15.9% of Pseudomonas aeruginosa isolates were multidrug resistant, and 52.6% of Acinetobacter species were multidrug resistant. The likelihood of HAIs caused by any of the six resistant bacteria ranged from 12% in inpatient rehabilitation facilities to 29% in long-term acute care hospitals.
Although there has been considerable progress in preventing some HAIs, many remaining infections could be prevented with implementation of existing recommended practices. Depending upon the setting, more than one in four of HAIs excluding CDI are caused by AR bacteria.
Physicians, nurses, and healthcare leaders need to consistently and comprehensively follow all recommendations to prevent catheter- and procedure-related infections and reduce the impact of AR bacteria through antimicrobial stewardship and measures to prevent spread.
医疗保健相关的抗生素耐药性(AR)感染会增加患者的发病率和死亡率,并且可能无法用任何抗生素成功治疗。美国疾病控制与预防中心(CDC)评估了医疗保健相关感染(HAI),包括艰难梭菌感染(CDI),以及全国范围内六种最受关注的AR细菌在几种类型医疗保健机构中的作用。
2014年期间,美国50个州的约4000家短期急性护理医院、501家长期急性护理医院和1135家住院康复机构向国家医疗安全网络报告了特定感染的数据。计算了每种HAI类型按机构类型划分的全国标准化感染率及其相对于基线年份的降低百分比。确定了由CDC在2013年强调为紧急或严重威胁的六种耐药细菌中的任何一种引起的AR病原体和HAI的比例。
2014年,短期急性护理医院和长期急性护理医院中心静脉导管相关血流感染的发病率分别降低了50%和9%;导尿管相关尿路感染的发病率在短期急性护理医院中降低了0%,在长期急性护理医院中降低了11%,在住院康复机构中降低了14%;手术部位感染在短期急性护理医院中降低了17%,CDI在短期急性护理医院中降低了8%。综合所有环境中除CDI之外的HAI,金黄色葡萄球菌分离株中47.9%对甲氧西林耐药,肠球菌中29.5%对万古霉素耐药,肠杆菌科细菌中17.8%为超广谱β-内酰胺酶表型,肠杆菌科细菌中3.6%对碳青霉烯类耐药,铜绿假单胞菌分离株中15.9%对多种药物耐药,不动杆菌属中52.6%对多种药物耐药。由六种耐药细菌中的任何一种引起的HAI的可能性在住院康复机构中为12%,在长期急性护理医院中为29%。
尽管在预防某些HAI方面取得了相当大的进展,但通过实施现有的推荐措施,许多剩余的感染是可以预防的。根据环境不同,除CDI之外的HAI中有超过四分之一是由AR细菌引起的。
医生、护士和医疗保健领导者需要始终如一地全面遵循所有建议,以预防与导管和操作相关的感染,并通过抗菌药物管理和预防传播的措施来减少AR细菌的影响。